Abbott (NYSE: ABT) announced today it has achieved new major milestones to support the company's growing suite of pulsed ...

More than 5,000 kids in the U.S. live with type 2 diabetes. The goal in this trial is reduce the number of insulin injections from multiple times a day to once a week.

ADMI applauds India's decision to maintain stringent clinical trial requirements for IVDs: Peethaambaran Kunnathoor, Chennai ...

Now, an innovative drug development trial will be available in emergency departments of 18 level 1 trauma sites nationwide. It is being launched by UC San Francisco and the Transforming Research and ...

The treatment combines a new drug, inavolisib, with two older breast cancer drugs, fulvestrant (Faslodex ®) and palbociclib (Ibrance ®) . Inavolisib, which targets PIK3CA mutations, appears to be a ...

Results of the first phase of the Ceramide Ring Trial have been published in Nature Communications, representing a ...

The FDA decision will enable Antag Therapeutics to initiate the clinical development of its lead candidate drug, a ...

Revolutionizes clinical trials with Zero Data Entry™, reducing costs and improving efficiency in clinical research ...

Chicago-based Vanqua Bio’s Parkinson’s disease drug has shown proof-of-concept in a first-in-human study, with the company to ...

The company is preparing for the Phase 3 study start in the first quarter of 2025BRISBANE, Calif., Oct. 10, 2024 (GLOBE ...

AI-based clinical simulation systems can be a game-changer for the pharmaceutical industry. The ability to predict clinical ...

DiaMedica Therapeutics has received the SAHPRA approval to commence a Phase II trial of DM199 to treat preeclampsia.